Bristol May Have Grounds For Fraud Case Against Apotex – Attorney
This article was originally published in The Pink Sheet Daily
Executive Summary
Wiley Rein & Fielding partner says Bristol-Myers Squibb may have a case against Apotex for sabotaging the Plavix settlement deal.
You may also be interested in...
Plavix Sales Plummet With Generic Entry
Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.
Plavix Sales Plummet With Generic Entry
Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.
Apotex Appeal On Plavix Preliminary Injunction Ruling To Begin Oct. 31
Appeals court denies Apotex' motion to stay a preliminary injunction blocking sales of generic clopidogrel.